2Hede K.Environmental protection:studies highlight importance of tumor microenvironment[J].J Natl Cancer Inst,2004,96(15):1120.
3Laconi E.The evolving concept of tumor microenvironments[J].Bioessays,2007,29:738.
4Fang JS,Gillies RD,Gatenby RA.Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression[J].Semin Cancer Biol,2008,18:330.
5Gillespie DL,Flynn JR,Ragel BT,et al.Silencing of HIF-1alpha by RNA interference in human glioma cells in vitro and in vivo[J].Methods Mol Biol,2009,487:283.
7Yu H,Zhang S,Zhang R,et al.The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma[J].J Exp Clin Cancer Res,2009,28:98.
8Guo B,Zhang Y,Luo G,et al.Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma[J].Anat Rec (Hoboken),2009,292(5):633.
9Lahat G,Lazar A,Wang X,et al,Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas[J].Clin Cancer Res,2009,15(8):2637.
10Timoshenko AV,Chakraborty C,Wagner GF,et al.COX-2 mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer[J].Br J Cancer,2006,94(8):1154.
3Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinase in Metastassis. J Natl Cancer inst, 1997,89(17):1260-1270.
4Behrens J. Cell contacts, differentiation, and invasiveness of epithelial cells. Invasion Metastasis, 1994 ; 14(1-6) : 61-70.
5Crawford HC, Matrisian LM. Tumor and stromal expression of matrix Metalloproteinases and their in tumor prodression. Invasion Metastasis, 1994 ; 14 (1-6) : 234-245.
6Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst, 1990 ;82(1) :4-6.
7Hardy CL. Homing of hematopoietic stem cells to the marrow. Am J Med Sci,1995,309(5):260-266.
8Kim CH, Broxmeyer HE. SLC/exodus2/6 Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells.. differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. supresslon of progenitor proliferation. J Leukoc Bio, 1999,66(3):455-461.
9Aiuti A, Tavian M, Cippon A,et al. Expression of CXCR4, the receptor for stromal cell derivetied factor-1 on fetal and adult human lympho-hematopoietie progenitors. Eur J Immunol, 1999,29(6) : 1823-1831.
10Burger M, Glodek A, Hartmann T, et al. Functional expression of CXCR4 (CD184) onsmall-cell lung cancer cells mediates migration integrin activation and adhesion to stromal cells. Oncogene,2003,22(50):8093-8101.
3Collins LG, Haines C, Perkel R, et al.Lung cancer: diagnosis and management[J].Am Fam Physician, 2007,75(1) : 56.
4Jemal A, Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin, 2009,59(4) : 225.
5DeVita VT Jr,Chu E. A history of cancer chemotherapy[J].Cancer Res, 2008,68(21) : 8643.
6Choi CH.ABC transporters as muhidrug resistance mechanisms and the development of chemosensitizers for their reversal[J].Cancer Cell Int, 2005,5:30.
7Zhang JY,Tao LY,Liang YJ, et al.Secalonic acid D induced leukemia cell apoptosis and cell cycle arrest of G(1) with involvement of.
8Tao LY,Liang YJ,Wang F,et al. Cediranib (recentin,AZD2171) reverses ABCB1- and ABCCl-mediated muhidrug resistance by inhibition of their transport function[J].Cancer Chemother Pharmacol, 2009,64(5):961.
9Tao LY ,Zhang JY, Liang Y J, et al. Anticancer effect and structureactivity analysis of marine products isolated from metabolites of mangrove fungi in the South China Sea[J].Mar Drags,8(4):1094.
